Lifecore Biomedical Raises Capital with Private Placement

$38.75 million Private Placement of Series A Convertible Preferred Stock to Support Working Capital and Capital Expenditures While Pursuing Ongoing...

Related Keywords

United States ,Jeff Sonnek ,Christopher Kiper ,Nathaniel Calloway ,Dan Mcdermott ,Jamesg Hall ,Exchange Commission ,Company Board Of Directors ,Nw Fund ,Lifecore Biomedical Inc ,Securities Exchange ,Private Placement ,Convertible Preferred Stock ,Support Working Capital ,Facilities Amended ,Increase Liquidity ,Provide Financial Covenant ,Christopher Kiper Appointed ,Legion Partners ,Wynnefield Capital ,Cove Street Partners ,Chief Executive Officer ,Information Regarding ,Convertible Preferred ,Securities Act ,Hyaluronic Acid ,Private Securities Litigation Reform Act ,Securities Exchange Act ,Quarterly Reports ,Annual Report ,Nasdaq Lfcr ,Lifecore Biomedical ,Nc ,